Tapewire

Nasdaq · USD

OABI

OmniAb, Inc.

Export transactions ↓
Tapewire entity
5294
SEC CIK
0001846253
Parsed reports
173

Last 12 months

Inside the activity.

2 purchase rows · 12 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202520
Dec 202503
Jan 202600
Feb 202606
Mar 202600
Apr 202603
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 01, 2022 Filed Nov 4, 2022 01:15 UTC
Boyce SarahDirector
GrantStock Option · Derivative 37,840 Not disclosed Strike: $9.10 Not disclosed
Disclosure

SEC source: 0000899243-22-035062 · doc4.xml · derivative · entry 5

Boyce Sarah · CIK 0001629383 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,840

Underlying: Common Stock · 37,840 shares

Expires 2032-06-10

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F5 · derivative.exercise_date: The stock option fully vests on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) on June 10, 2023.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:15 UTC
Boyce SarahDirector
GrantStock Option · Derivative 13,994 Not disclosed Strike: $13.24 Not disclosed
Disclosure

SEC source: 0000899243-22-035062 · doc4.xml · derivative · entry 4

Boyce Sarah · CIK 0001629383 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,994

Underlying: Common Stock · 13,994 shares

Expires 2031-06-04

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:15 UTC
Boyce SarahDirector
GrantStock Option · Derivative 10,565 Not disclosed Strike: $13.49 Not disclosed
Disclosure

SEC source: 0000899243-22-035062 · doc4.xml · derivative · entry 3

Boyce Sarah · CIK 0001629383 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,565

Underlying: Common Stock · 10,565 shares

Expires 2030-06-10

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:15 UTC
Boyce SarahDirector
GrantStock Option · Derivative 22,616 Not disclosed Strike: $12.37 Not disclosed
Disclosure

SEC source: 0000899243-22-035062 · doc4.xml · derivative · entry 2

Boyce Sarah · CIK 0001629383 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,616

Underlying: Common Stock · 22,616 shares

Expires 2029-10-15

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:15 UTC
Boyce SarahDirector
GrantCommon Stock 37,437 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-035062 · doc4.xml · nonDerivative · entry 1

Boyce Sarah · CIK 0001629383 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,437

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F2 · shares: Includes 8,753 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and does not expire.

F3 · shares: Includes 14,512 earn-out shares subject to forfeiture provisions described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:12 UTC
GUSTAFSON KURT AEVP, Finance and CFO
GrantStock Option · Derivative 348,760 Not disclosed Strike: $12.39 Not disclosed
Disclosure

SEC source: 0000899243-22-035053 · doc4.xml · derivative · entry 2

GUSTAFSON KURT A · CIK 0001462354 · EVP, Finance and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 348,760

Underlying: Common Stock · 348,760 shares

Expires 2032-04-08

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on October 8, 2022, and in 42 substantially equal monthly installments thereafter.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:12 UTC
GUSTAFSON KURT AEVP, Finance and CFO
GrantCommon Stock 160,062 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-035053 · doc4.xml · nonDerivative · entry 1

GUSTAFSON KURT A · CIK 0001462354 · EVP, Finance and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,062

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F2 · shares: Includes 69,752 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and does not expire.

F3 · shares: Includes 72,872 earn-out shares subject to forfeiture provisions described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:10 UTC
FOEHR MATTHEW WDirector · President & CEO
GrantStock Option · Derivative 298,311 Not disclosed Strike: $10.41 Not disclosed
Disclosure

SEC source: 0000899243-22-035050 · doc4.xml · derivative · entry 10

FOEHR MATTHEW W · CIK 0001237556 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 298,311

Underlying: Common Stock · 298,311 shares

Expires 2032-05-05

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F8 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on August 5, 2022, and in 42 substantially equal monthly installments thereafter.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:10 UTC
FOEHR MATTHEW WDirector · President & CEO
GrantStock Option · Derivative 56,233 Not disclosed Strike: $20.36 Not disclosed
Disclosure

SEC source: 0000899243-22-035050 · doc4.xml · derivative · entry 9

FOEHR MATTHEW W · CIK 0001237556 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,233

Underlying: Common Stock · 56,233 shares

Expires 2031-02-03

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F7 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on August 3, 2021, and in 42 substantially equal monthly installments thereafter.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:10 UTC
FOEHR MATTHEW WDirector · President & CEO
GrantStock Option · Derivative 142,168 Not disclosed Strike: $10.98 Not disclosed
Disclosure

SEC source: 0000899243-22-035050 · doc4.xml · derivative · entry 8

FOEHR MATTHEW W · CIK 0001237556 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,168

Underlying: Common Stock · 142,168 shares

Expires 2030-02-13

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F6 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on August 13, 2020, and in 42 substantially equal monthly installments thereafter.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:10 UTC
FOEHR MATTHEW WDirector · President & CEO
GrantStock Option · Derivative 146,325 Not disclosed Strike: $13.54 Not disclosed
Disclosure

SEC source: 0000899243-22-035050 · doc4.xml · derivative · entry 7

FOEHR MATTHEW W · CIK 0001237556 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,325

Underlying: Common Stock · 146,325 shares

Expires 2029-02-11

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F5 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on August 11, 2019, and in 42 substantially equal monthly installments thereafter.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:10 UTC
FOEHR MATTHEW WDirector · President & CEO
GrantStock Option · Derivative 86,790 Not disclosed Strike: $18.24 Not disclosed
Disclosure

SEC source: 0000899243-22-035050 · doc4.xml · derivative · entry 6

FOEHR MATTHEW W · CIK 0001237556 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,790

Underlying: Common Stock · 86,790 shares

Expires 2028-03-02

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:10 UTC
FOEHR MATTHEW WDirector · President & CEO
GrantStock Option · Derivative 104,231 Not disclosed Strike: $11.52 Not disclosed
Disclosure

SEC source: 0000899243-22-035050 · doc4.xml · derivative · entry 5

FOEHR MATTHEW W · CIK 0001237556 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,231

Underlying: Common Stock · 104,231 shares

Expires 2027-02-24

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:10 UTC
FOEHR MATTHEW WDirector · President & CEO
GrantStock Option · Derivative 111,038 Not disclosed Strike: $9.84 Not disclosed
Disclosure

SEC source: 0000899243-22-035050 · doc4.xml · derivative · entry 4

FOEHR MATTHEW W · CIK 0001237556 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,038

Underlying: Common Stock · 111,038 shares

Expires 2026-02-11

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:10 UTC
FOEHR MATTHEW WDirector · President & CEO
GrantStock Option · Derivative 172,768 Not disclosed Strike: $6.46 Not disclosed
Disclosure

SEC source: 0000899243-22-035050 · doc4.xml · derivative · entry 3

FOEHR MATTHEW W · CIK 0001237556 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,768

Underlying: Common Stock · 172,768 shares

Expires 2025-02-10

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:10 UTC
FOEHR MATTHEW WDirector · President & CEO
GrantStock Option · Derivative 270,595 Not disclosed Strike: $8.54 Not disclosed
Disclosure

SEC source: 0000899243-22-035050 · doc4.xml · derivative · entry 2

FOEHR MATTHEW W · CIK 0001237556 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,595

Underlying: Common Stock · 270,595 shares

Expires 2024-02-12

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:10 UTC
FOEHR MATTHEW WDirector · President & CEO
GrantCommon Stock 1,305,350 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-035050 · doc4.xml · nonDerivative · entry 1

FOEHR MATTHEW W · CIK 0001237556 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,305,350

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F2 · shares: Includes 176,076 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and does not expire.

F3 · shares: Includes 264,760 earn-out shares subject to forfeiture provisions described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:15 UTC GrantStock Option · Derivative 107,506 Not disclosed Strike: $20.36 Not disclosed
Disclosure

SEC source: 0000899243-22-035061 · doc4.xml · derivative · entry 12

HIGGINS JOHN L · CIK 0001208906 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,506

Underlying: Common Stock · 107,506 shares

Expires 2031-02-03

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F7 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on August 3, 2021, and in 42 substantially equal monthly installments thereafter.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:15 UTC GrantStock Option · Derivative 260,646 Not disclosed Strike: $10.98 Not disclosed
Disclosure

SEC source: 0000899243-22-035061 · doc4.xml · derivative · entry 11

HIGGINS JOHN L · CIK 0001208906 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,646

Underlying: Common Stock · 260,646 shares

Expires 2030-02-13

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F6 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on August 13, 2020, and in 42 substantially equal monthly installments thereafter.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:15 UTC GrantStock Option · Derivative 250,843 Not disclosed Strike: $13.54 Not disclosed
Disclosure

SEC source: 0000899243-22-035061 · doc4.xml · derivative · entry 10

HIGGINS JOHN L · CIK 0001208906 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,843

Underlying: Common Stock · 250,843 shares

Expires 2029-02-11

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F5 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on August 11, 2019, and in 42 substantially equal monthly installments thereafter.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:15 UTC GrantStock Option · Derivative 177,194 Not disclosed Strike: $18.24 Not disclosed
Disclosure

SEC source: 0000899243-22-035061 · doc4.xml · derivative · entry 9

HIGGINS JOHN L · CIK 0001208906 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 177,194

Underlying: Common Stock · 177,194 shares

Expires 2028-03-02

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:15 UTC GrantStock Option · Derivative 186,843 Not disclosed Strike: $11.52 Not disclosed
Disclosure

SEC source: 0000899243-22-035061 · doc4.xml · derivative · entry 8

HIGGINS JOHN L · CIK 0001208906 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,843

Underlying: Common Stock · 186,843 shares

Expires 2027-02-24

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:15 UTC GrantStock Option · Derivative 232,136 Not disclosed Strike: $9.84 Not disclosed
Disclosure

SEC source: 0000899243-22-035061 · doc4.xml · derivative · entry 7

HIGGINS JOHN L · CIK 0001208906 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 232,136

Underlying: Common Stock · 232,136 shares

Expires 2026-02-11

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:15 UTC GrantStock Option · Derivative 232,971 Not disclosed Strike: $6.46 Not disclosed
Disclosure

SEC source: 0000899243-22-035061 · doc4.xml · derivative · entry 6

HIGGINS JOHN L · CIK 0001208906 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 232,971

Underlying: Common Stock · 232,971 shares

Expires 2025-02-10

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:15 UTC GrantStock Option · Derivative 400,808 Not disclosed Strike: $8.54 Not disclosed
Disclosure

SEC source: 0000899243-22-035061 · doc4.xml · derivative · entry 5

HIGGINS JOHN L · CIK 0001208906 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,808

Underlying: Common Stock · 400,808 shares

Expires 2024-02-12

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:15 UTC GrantStock Option · Derivative 61,362 Not disclosed Strike: $3.68 Not disclosed
Disclosure

SEC source: 0000899243-22-035061 · doc4.xml · derivative · entry 4

HIGGINS JOHN L · CIK 0001208906 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,362

Underlying: Common Stock · 61,362 shares

Expires 2023-06-03

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:15 UTC GrantStock Option · Derivative 246,648 Not disclosed Strike: $2.52 Not disclosed
Disclosure

SEC source: 0000899243-22-035061 · doc4.xml · derivative · entry 3

HIGGINS JOHN L · CIK 0001208906 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,648

Underlying: Common Stock · 246,648 shares

Expires 2023-02-15

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:15 UTC GrantCommon Stock 2,176,521 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-035061 · doc4.xml · nonDerivative · entry 1

HIGGINS JOHN L · CIK 0001208906 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,176,521

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F2 · shares: Includes 183,384 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and does not expire.

F3 · shares: Includes 362,232 earn-out shares subject to forfeiture provisions described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:16 UTC GrantStock Option · Derivative 175,477 Not disclosed Strike: $10.41 Not disclosed
Disclosure

SEC source: 0000899243-22-035063 · doc4.xml · derivative · entry 9

Berkman Charles S · CIK 0001392266 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,477

Underlying: Common Stock · 175,477 shares

Expires 2032-05-05

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F8 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on August 5, 2022, and in 42 substantially equal monthly installments thereafter.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:16 UTC GrantStock Option · Derivative 29,772 Not disclosed Strike: $20.36 Not disclosed
Disclosure

SEC source: 0000899243-22-035063 · doc4.xml · derivative · entry 8

Berkman Charles S · CIK 0001392266 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,772

Underlying: Common Stock · 29,772 shares

Expires 2031-02-03

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F7 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on August 3, 2021, and in 42 substantially equal monthly installments thereafter.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:16 UTC GrantStock Option · Derivative 73,716 Not disclosed Strike: $10.98 Not disclosed
Disclosure

SEC source: 0000899243-22-035063 · doc4.xml · derivative · entry 7

Berkman Charles S · CIK 0001392266 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,716

Underlying: Common Stock · 73,716 shares

Expires 2030-02-13

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F6 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on August 13, 2020, and in 42 substantially equal monthly installments thereafter.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:16 UTC GrantStock Option · Derivative 62,710 Not disclosed Strike: $13.54 Not disclosed
Disclosure

SEC source: 0000899243-22-035063 · doc4.xml · derivative · entry 6

Berkman Charles S · CIK 0001392266 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,710

Underlying: Common Stock · 62,710 shares

Expires 2029-02-11

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F5 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on August 11, 2019, and in 42 substantially equal monthly installments thereafter.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:16 UTC GrantStock Option · Derivative 39,777 Not disclosed Strike: $18.24 Not disclosed
Disclosure

SEC source: 0000899243-22-035063 · doc4.xml · derivative · entry 5

Berkman Charles S · CIK 0001392266 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,777

Underlying: Common Stock · 39,777 shares

Expires 2028-03-02

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:16 UTC GrantStock Option · Derivative 29,237 Not disclosed Strike: $11.52 Not disclosed
Disclosure

SEC source: 0000899243-22-035063 · doc4.xml · derivative · entry 4

Berkman Charles S · CIK 0001392266 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,237

Underlying: Common Stock · 29,237 shares

Expires 2027-02-24

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:16 UTC GrantStock Option · Derivative 17,778 Not disclosed Strike: $9.84 Not disclosed
Disclosure

SEC source: 0000899243-22-035063 · doc4.xml · derivative · entry 3

Berkman Charles S · CIK 0001392266 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,778

Underlying: Common Stock · 17,778 shares

Expires 2026-02-11

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:16 UTC GrantStock Option · Derivative 8,339 Not disclosed Strike: $6.46 Not disclosed
Disclosure

SEC source: 0000899243-22-035063 · doc4.xml · derivative · entry 2

Berkman Charles S · CIK 0001392266 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,339

Underlying: Common Stock · 8,339 shares

Expires 2025-02-10

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:16 UTC GrantCommon Stock 353,716 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-035063 · doc4.xml · nonDerivative · entry 1

Berkman Charles S · CIK 0001392266 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 353,716

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F2 · shares: Includes 97,769 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and does not expire.

F3 · shares: Includes 96,038 earn-out shares subject to forfeiture provisions described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 21:14 UTC
Patel SunilDirector
GrantStock Option · Derivative 37,840 Not disclosed Strike: $9.10 Not disclosed
Disclosure

SEC source: 0000899243-22-035058 · doc4.xml · derivative · entry 10

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,840

Underlying: Common Stock · 37,840 shares

Expires 2032-06-10

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F5 · derivative.exercise_date: The stock option fully vests on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) on June 10, 2023.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 21:14 UTC
Patel SunilDirector
GrantStock Option · Derivative 13,994 Not disclosed Strike: $13.24 Not disclosed
Disclosure

SEC source: 0000899243-22-035058 · doc4.xml · derivative · entry 9

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,994

Underlying: Common Stock · 13,994 shares

Expires 2031-06-04

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 21:14 UTC
Patel SunilDirector
GrantStock Option · Derivative 10,565 Not disclosed Strike: $13.49 Not disclosed
Disclosure

SEC source: 0000899243-22-035058 · doc4.xml · derivative · entry 8

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,565

Underlying: Common Stock · 10,565 shares

Expires 2030-06-10

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 21:14 UTC
Patel SunilDirector
GrantStock Option · Derivative 17,427 Not disclosed Strike: $13.03 Not disclosed
Disclosure

SEC source: 0000899243-22-035058 · doc4.xml · derivative · entry 7

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,427

Underlying: Common Stock · 17,427 shares

Expires 2029-06-06

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 21:14 UTC
Patel SunilDirector
GrantStock Option · Derivative 10,590 Not disclosed Strike: $22.47 Not disclosed
Disclosure

SEC source: 0000899243-22-035058 · doc4.xml · derivative · entry 6

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,590

Underlying: Common Stock · 10,590 shares

Expires 2028-06-19

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 21:14 UTC
Patel SunilDirector
GrantStock Option · Derivative 10,513 Not disclosed Strike: $13.02 Not disclosed
Disclosure

SEC source: 0000899243-22-035058 · doc4.xml · derivative · entry 5

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,513

Underlying: Common Stock · 10,513 shares

Expires 2027-05-25

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 21:14 UTC
Patel SunilDirector
GrantStock Option · Derivative 9,970 Not disclosed Strike: $13.69 Not disclosed
Disclosure

SEC source: 0000899243-22-035058 · doc4.xml · derivative · entry 4

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,970

Underlying: Common Stock · 9,970 shares

Expires 2026-05-23

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 21:14 UTC
Patel SunilDirector
GrantStock Option · Derivative 11,789 Not disclosed Strike: $10.30 Not disclosed
Disclosure

SEC source: 0000899243-22-035058 · doc4.xml · derivative · entry 3

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,789

Underlying: Common Stock · 11,789 shares

Expires 2025-04-24

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 21:14 UTC
Patel SunilDirector
GrantStock Option · Derivative 14,178 Not disclosed Strike: $7.75 Not disclosed
Disclosure

SEC source: 0000899243-22-035058 · doc4.xml · derivative · entry 2

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,178

Underlying: Common Stock · 14,178 shares

Expires 2024-06-04

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 21:14 UTC
Patel SunilDirector
GrantCommon Stock 172,512 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-035058 · doc4.xml · nonDerivative · entry 1

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,512

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F2 · shares: Includes 8,753 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and does not expire.

F3 · shares: Includes 22,538 earn-out shares subject to forfeiture provisions described in the Merger Agreement.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

Read SEC document
November 01, 2022 Filed Apr 23, 2024 21:40 UTC Amendment GrantCommon Stock 25,518 Not disclosed Not disclosed
Disclosure

SEC source: 0001846253-24-000011 · wk-form4a_1713908398.xml · nonDerivative · entry 1

Cochran Jennifer R. · CIK 0001872349 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,378

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F2 · shares: This amendment is being filed to correct a Form 4 filed on November 3, 2022, which inadvertently understated the number of shares beneficially held by the Reporting Person following the transaction reported by 292 shares. The number reported in column 4 represents the correct number of shares acquired by the Reporting Person as of November 1, 2022, which included (1) 12,545 restricted stock units and (2) 11,076 earn-out shares.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F3 · balance_after: Represents the number of shares beneficially held by the Reporting Person as of the date of this filing, as adjusted for the administrative error identified in footnote 2.

Read SEC document
November 01, 2022 Filed Apr 23, 2024 21:37 UTC Amendment
Boyce SarahDirector
GrantCommon Stock 39,628 Not disclosed Not disclosed
Disclosure

SEC source: 0001846253-24-000009 · wk-form4a_1713908240.xml · nonDerivative · entry 1

Boyce Sarah · CIK 0001629383 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,381

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F2 · shares: This amendment is being filed to correct a Form 4 filed on November 3, 2022, which inadvertently understated the number of shares beneficially held by the Reporting Person following the transaction reported by 2,191 shares. The number reported in column 4 represents the correct number of shares acquired by the Reporting Person as of November 1, 2022, which included (1) 8,753 restricted stock units and (2) 16,704 earn-out shares.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F3 · balance_after: Represents the number of shares beneficially held by the Reporting Person as of the date of this filing, as adjusted for the administrative error identified in footnote 2.

Read SEC document
November 01, 2022 Filed Apr 23, 2024 21:44 UTC Amendment
FOEHR MATTHEW WDirector · President and CEO
GrantCommon Stock 1,431,618 Not disclosed Not disclosed
Disclosure

SEC source: 0001846253-24-000014 · wk-form4a_1713908655.xml · nonDerivative · entry 1

FOEHR MATTHEW W · CIK 0001237556 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,296,665

F1 · kind: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F2 · shares: This amendment is being filed to correct a Form 4 filed on November 3, 2022, which inadvertently understated the number of shares beneficially held by the Reporting Person following the transaction reported by 126,268 shares. The number reported in column 4 represents the correct number of shares acquired by the Reporting Person as of November 1, 2022, which included (1) 176,076 restricted stock units and (2) 391,030 earn-out shares.

F1 · price: Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.

F3 · balance_after: Represents the number of shares beneficially held by the Reporting Person as of the date of this filing, as adjusted for the administrative error identified in footnote 2.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.